Cargando…
New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation
BACKGROUND: Cancer is still a major world health threat, causing a high rate of mortality. VEGFR-2 inhibitor anticancer agents are of great significance. However, they showed some serious side effects. PURPOSE: To discover new effective and safer anticancer agents, a new series of piperazinylquinoxa...
Autores principales: | Abdallah, Abdallah E, Mabrouk, Reda R, Elnagar, Mohamed R, Farrag, Amel Mostafa, Kalaba, Mohamed H, Sharaf, Mohamed H, El-Fakharany, Esmail M, Bakhotmah, Dina Abed, Elkaeed, Eslam B, Al Ward, Maged Mohammed Saleh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904266/ https://www.ncbi.nlm.nih.gov/pubmed/35281317 http://dx.doi.org/10.2147/DDDT.S344750 |
Ejemplares similares
-
Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors
por: Abdallah, Abdallah E., et al.
Publicado: (2022) -
Antifungal and antibiofilm activities of bee venom loaded on chitosan nanoparticles: a novel approach for combating fungal human pathogens
por: El-Didamony, Samia E., et al.
Publicado: (2022) -
Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2
por: Eissa, Ibrahim H., et al.
Publicado: (2023) -
A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies
por: Eissa, Ibrahim H., et al.
Publicado: (2023) -
Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents
por: Kotb, Anas Ramadan, et al.
Publicado: (2023)